Jyong Bio (MENS) Net Margin

Brandmark of Jyong Biotech Limited (MENS)

Jyong Biotech Ltd is scaling the distribution of innovative urological products through Asian pharmacy chains. Production is based in China and Taiwan, leveraging patented herbal formulations. The net margin structure demonstrates sustainable profitability, with the indicator fixed at 0.00. The competitive advantage of MENS lies in a rigorous clinical foundation for its formulas, bridging the gap between traditional approaches and FDA standards.

jyongbio.com (MENS) - Net Profitability Margin from 06/18/2025 to 11/20/2026

Financial and market metric breakdowns for Jyong Biotech Corp (MENS)

- market value and analyst target forecast:
Analysis of all company metrics:Jyong Biotech Ltd
Flagship merchandise of Jyong Biotech Limited

Jyong Biotech Ltd (MENS) is a micro-cap company with limited commercial experience and a lack of stable revenue streams, rendering the business dependent on external funding. Analyzing the net profit margin relative to revenue helps uncover hidden operational flaws and distinguish speculative growth from genuine efficiency; therefore, the stability of sales margins serves as a key criterion for assessing the issuer's financial viability.

Analysis of competing companies

HLN: Net Sales Margin|Net Return on Sales KVUE|Net Margin veronapharma.com|Net Sales Margin Ligand Corp|Net Sales Margin AMRX|Company Sales Margin Perrigo Company plc|Net Sales Margin ALVO (Alvotech Biopharmaceuticals)|LQDA: Net Return on Sales|Galapagos N.V. - Net Sales Margin|ANIP - Net Sales Margin|MNKD: Net Sales Margin|amphastar.com (AMPH) - Net Sales Margin|PCRX (Pacira Pharmaceuticals) - Net Sales Margin|Return on Sales by Net Profit ARS Pharmaceuticals, Inc. (SPRY)|Net Sales Margin TBPH|AQST (Aquestive Therapeutics) - Net Profit Rate|scPharmaceuticals, Inc. - Return on Sales by Net Profit|Net Profit Rate TECX|tonixpharma.com - Net Sales Margin|Net Profit Rate SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Net Margin|Return on Sales by Net Profit BioHarvest|Return on Sales by Net Profit EXOZ|Return on Sales by Net Profit Oramed Pharmaceuticals (ORMP)|Return on Sales by Net Profit ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Net Return on Sales|Net Sales Margin ABVC (ABVC BioPharma Inc)|CPIX - Return on Sales by Net Profit|Quantum BioPharma Corp - Net Sales Margin|FGEN (fibrogen.com) - Net Return on Sales|TELO (Telomir Pharmaceuticals) - Return on Sales by Net Profit|Rani Therapeutics Holdings - Net Profit Rate|Return on Sales by Net Profit SNYR|Net Margin rallybio.com RLYB|Net Sales Margin LEXX|PULM (Pulmatrix, Inc.) - Net Profit Rate|Pheton Holdings - Return on Sales by Net Profit|Net Sales Margin Aptorum Group Limited APM|LYRA: Return on Sales by Net Profit|IBO: Net Margin|TNFA: Net Sales Margin|YCBD: Company Net Profitability|Net Margin PainReform Ltd|CYTO (altamiratherapeutics.com) - Company Net Profitability|Net Sales Margin LIPO|OPTN - Net Margin|Net Margin pieris.com PIRS|Net Profit Rate PROC|PTPI - Net Margin|Qilian International Holding (QLI) - Return on Sales by Net Profit|SLRN: Net Sales Margin|Return on Sales by Net Profit TFF Pharma